MYCN and medulloblastoma: Transactivated by HIF-1α, MYC is a prominent biological determinant in SHH (MYCN) and group 3 (MYCC) medulloblastoma but has not been widely implicated in group 4 biology, although MYCN amplifications are infrequently observed [48].